Ipsen Bioscience News Today

Pancreatic cancer is one of the deadliest cancers-;only about one in eight patients survives five years after diagnosis.

Operator: Good afternoon, ladies and gentlemen, and welcome to the BioAtla Third Quarter 2023 Earnings Call. At this time, all lines are in a listen-only mode.

In a decision handed down by Associate Justice Neil Gorsuch, the Court held that Amgen "failed to enable any person skilled in the art . . . to make and use the invention as defined by the relevant claims."

The Supreme Court's consideration of the standards for satisfying the enablement provisions of 35 U.S.C. 112(a) has been occasioned for the first time in over a century by the Court's...

/PRNewswire/ -- The "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering....

/PRNewswire/ -- The "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.coms offering....

Vifor Pharma to propose Dr Alexandre LeBeaut as Board member Dr Alexandre LeBeaut to be proposed to Annual General Meeting for appointment to Board Dr Gianni Zampieri and Gilbert Achermann will not stand for re-election Regulatory News: Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021. Jacques Theurillat, Chairman of Vifor Pharma, commented: “We are very pleased to nominate Ale...

Press release content from Business Wire. The AP news staff was not involved in its creation. Vifor Pharma to propose Dr Alexandre LeBeaut as Board member February 2, 2021 GMT Regulatory News: Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021. Jacques Theurillat, Chairman of Vifor Pharma, commented: “We are very pleased to nominate Alexandre LeBeaut for election to the Vifor Pha...